# 2026-00626: Indiana Doc Ghosts DEA, Loses Rights to Prescribe Controlled Drugs

2026-00626, Walter Walters, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-01-15, effective 2026-02-17 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-00626
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-00626
- Title: Walter Walters, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 1816
- Published: 2026-01-15
- Effective: 2026-02-17
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Indiana Doc Ghosts DEA, Loses Rights to Prescribe Controlled Drugs

## Summary

Dr. Walter Walters from Indiana lost his DEA registration because he no longer has the legal right to handle controlled substances in his state. Despite multiple attempts, he didn’t respond or ask for a hearing, so the DEA officially revoked his certificate. This means he can’t prescribe or manage controlled drugs anymore, effective immediately, impacting his medical practice and patients.

## Effects PRIA read

- DEA Registration Revoked for Indiana Physician: cost, high. The DEA revoked Certificate of Registration No. FW6683331 issued to Walter Walters, M.D., because he is not authorized to handle controlled substances in Indiana. The Order also denies any pending applications to renew, modify, or add a DEA registration for Dr. Walters in Indiana. The revocation an…
- Short Window to Seek Reconsideration: mixed, low. The Order states that the registrant may dispute the Agency's finding by filing a properly supported motion for reconsideration of findings of fact within fifteen calendar days of the date of this Order. Any such motion and response must be filed and served by email to the other party and to the DE…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-00626 on federalregister.gov](https://www.federalregister.gov/documents/2026/01/15/2026-00626/walter-walters-md-decision-and-order)
- [2026-00626 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-01-15/pdf/2026-00626.pdf)

## Related
- [Previous: 2026-00625, South Central Florida Express, Inc.-Trackage Rights Exemption-Florida East Coas…](https://policyrisk.com/federal-register/2026-00625)
- [Next: 2026-00627, Jason Vanshaar, M.D.; Decision and Order](https://policyrisk.com/federal-register/2026-00627)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-00626 (as of 2026-06-08).
